Literature DB >> 12746163

Glomerular filtration rate in children with solid tumors: normative values and a new method for estimation.

J R Brandt1, Craig Wong, D R Jones, C Qualls, N McAfee, E Brewer, S L Watkins.   

Abstract

Many chemotherapy regimens used in children are nephrotoxic. Accurate dosing of these medications requires that some estimation of glomerular filtration rate (GFR) be performed prior to initiating chemotherapy. However, few studies evaluating normal GFR in children exist. The authors report normal values for GFR for children with nonhematogenous malignancies using a highly accurate method of directly measuring GFR and an equation for estimating absolute GFR in these children. Children with nonhematogenous malignancies with no evidence of renal involvement or prior use of nephrotoxic agents had their GFR measured using an iothalamate infusion methodology. A total of 111 children (males and females) with a mean age = 7.95 years (range 2.8 months-19.5 years) were included in the study. GFR adjusted for body surface area (mL/min/1.73 m(2)) increases in the first 2 years of life and then plateaus at a level comparable to adult values. GFR adjusted for body surface area for males >2 years = 131.3 +/- 22.5, females = 126.8 +/- 24.4 mL/min/1.73 m(2) (p value not significant). Absolute GFR in mL/min can be easily estimated by a simple formula (r(2) =.97) based on the child's weight and serum creatinine: GFR (mL/min) = k sqrt[ ( (agemos+ 6)* wt) / Cr serum ] where agemos is age in months, wt is weight in kg, and k = 1.05 for males and 0.95 for females. The accurate measurement of GFR remains vitally important in the safe and effective treatment of pediatric solid tumors. This study provides a set of normal GFR values for these children and an equation for easy estimate of absolute GFR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746163

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  8 in total

1.  Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2).

Authors:  Hans Pottel; Liesbeth Hoste; Pierre Delanaye
Journal:  Pediatr Nephrol       Date:  2014-11-19       Impact factor: 3.714

2.  Estimating absolute glomerular filtration rate in children.

Authors:  John R Brandt; Craig S Wong; Jeffery D Hanrahan; Clifford Qualls; Nancy McAfee; Sandra L Watkins
Journal:  Pediatr Nephrol       Date:  2006-09-30       Impact factor: 3.714

3.  Glomerular hyperfiltration in children with cancer: prevalence and a hypothesis.

Authors:  Neha S Kwatra; Holly J Meany; Sunil J Ghelani; David Zahavi; Nayan Pandya; Massoud Majd
Journal:  Pediatr Radiol       Date:  2016-11-03

4.  Validation of the revised Schwartz estimating equation in a predominantly non-CKD population.

Authors:  Amy Staples; Robin LeBlond; Sandra Watkins; Craig Wong; John Brandt
Journal:  Pediatr Nephrol       Date:  2010-07-22       Impact factor: 3.714

5.  Validation of child serum creatinine-based prediction equations for glomerular filtration rate.

Authors:  Michael Zappitelli; Lawrence Joseph; Indra R Gupta; Lorraine Bell; Gilles Paradis
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

6.  Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients.

Authors:  Vanessa E Millisor; Jessica K Roberts; Yilun Sun; Li Tang; Vinay M Daryani; David Gregornik; Shane J Cross; Deborah Ward; Jennifer L Pauley; Alejandro Molinelli; Rachel C Brennan; Clinton F Stewart
Journal:  Pediatr Nephrol       Date:  2017-06-02       Impact factor: 3.714

7.  Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.

Authors:  Trevor McKibbin; John C Panetta; Maryam Fouladi; Amar Gajjar; Feng Bai; M Fatih Okcu; Clinton F Stewart
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

8.  Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.

Authors:  Mirjam E van de Velde; Emil den Bakker; Hester N Blufpand; Gertjan L Kaspers; Floor C H Abbink; Arjenne W A Kors; Abraham J Wilhelm; Richard J Honeywell; Godefridus J Peters; Birgit Stoffel-Wagner; Laurien M Buffart; Arend Bökenkamp
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.